Similar Papers

Paper Title
Journal
Date
Author
A retrospective analysis of patients with complete response (CR) after FOLFOX4: Single institute experience
...
Journal of Clinical Oncology | VOL. 26
, et. al. ...
20 May 2008
Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte.
...
Blood | VOL. 114
, et. al. ...
20 Nov 2009
Investigation of Using Diffusion-Weighted Magnetic Resonance Imaging (DWI) Combined with CT and Esophagogram to Evaluate the Therapeutic Effect of Esophageal Squamous Cell Carcinoma (ESCC) Treated with Chemoradiotherapy
X Ren ... C Han
International Journal of Radiation Oncology*Biology*Physics | VOL. 105
X Ren, et. al.X Ren ... C Han
01 Sep 2019
Long‐term follow‐up of patients with HIV‐related diffuse large B‐cell lymphomas treated in a phase II study with rituximab and CHOP
Josep‐Maria Ribera ... Jose‐Tomas Navarro
British Journal of Haematology | VOL. 157
Josep‐Maria Ribera, et. al.Josep‐Maria Ribera ... Jose‐Tomas Navarro
07 Feb 2012
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Brentuximab vedotin and nivolumab for cHL.
-
Blood | VOL. 145
--
16 Jan 2025
B-1 B cells lose self-control in SCD.
David R Gibb ... Sean R Stowell
Blood | VOL. 145
David R Gibb, et. al.David R Gibb ... Sean R Stowell
16 Jan 2025
Is it time to screen for multiple myeloma?
Irene M Ghobrial ... Floris Chabrun
Blood | VOL. 145
Irene M Ghobrial, et. al.Irene M Ghobrial ... Floris Chabrun
16 Jan 2025
Daratumumab for maintenance in myeloma.
Cyrille Touzeau ... Aurore Perrot
Blood | VOL. 145
Cyrille Touzeau, et. al.Cyrille Touzeau ... Aurore Perrot
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.